Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Biovivotech AS
AS
Active
Org 994974610
Sjøgata 21, 8006
Bodø
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2010 · 16 years old
1 employees
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Biovivotech AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
5M
4M
2M
1M
0M
2021: 4M
4M
2021
2022: 2M (-50% vs 2021)
2M
-50%
2022
2023: 3M (+50% vs 2022)
3M
+50%
2023
2024: 3M (0% vs 2023)
3M
0%
2024
2025: 1M (-67% vs 2024)
1M
-67%
2025
EBITDA
NOK millions
1M
1M
1M
0M
0M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 1M
1M
2024
2025: 0M (-100% vs 2024)
0M
-100%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
1 466
2 748
3 196
2 466
3 841
Staff expenses
−807
−684
−911
−766
−607
EBITDA
78
643
305
176
146
Depreciation & amort.
−48
−49
−67
−19
−17
EBIT
31
594
238
157
128
Net financials
−34
−3
−22
−3
−19
Profit before tax
−3
591
217
154
109
Tax
−0
−0
−0
−0
−0
Net profit
−3
591
217
154
109
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
2 429
3 175
2 901
3 012
2 786
Equity
1 280
1 283
692
475
321
Long-term debt
0
655
669
492
483
Short-term debt
511
1 237
1 540
2 045
1 981
Total debt
1 149
1 892
2 209
2 537
2 464
Financial ratios
5-year trend
EBITDA margin
5,3 %
This company
15,8 %
Market median
This company
Market median
66% below market
2021
2025
Equity ratio
52,7 %
This company
38,2 %
Market median
This company
Market median
38% above market
2021
2025
Return on equity
−0,3 %
This company
18,4 %
Market median
This company
Market median
102% below market
2021
2025
Net profit margin
−0,2 %
This company
8,1 %
Market median
This company
Market median
102% below market
2021
2025
Asset turnover
0,60×
This company
1,12×
Market median
This company
Market median
46% below market
2021
2025
Debt / equity
0,90×
This company
0,62×
Market median
This company
Market median
45% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Biovivotech AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
